BREAKING:
Several peptides previously flagged under FDA compounding restrictions have reportedly been removed from the Category 2 concern list, including BPC-157, TB-500, GHK-Cu, Semax, MOTS-c, and others.
They still are not FDA approved drugs, but the regulatory landscape around compounding may be shifting again.
Prepare to pay $3000 / month for Semax
We literally have a 100% free
peptide community that shares not only case studies but MORE IMPORTANTLY
Anecdotal accounts
Most peptides aren’t being studied due to big pharma’s inability to profit off of a majority of them
Don’t be a sheep that buys blindly based off of tiktok bot comments
Join our community, see real results from real people and make your decision then